Have a personal or library account? Click to login
Evaluation of the social and economic burden of road traffic noise-attributed myocardial infarction in Bulgarian urban population / Procjena socijalnog i ekonomskog tereta infarkta miokarda povezanog s cestovnom bukom u bugarskog urbanog stanovništva Cover

Evaluation of the social and economic burden of road traffic noise-attributed myocardial infarction in Bulgarian urban population / Procjena socijalnog i ekonomskog tereta infarkta miokarda povezanog s cestovnom bukom u bugarskog urbanog stanovništva

Open Access
|Mar 2015

References

  1. 1. Ganova-Iolovska M, Kalinov K, Geraedts M. Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study. BMC Health Serv Res 2009;9:15. doi: 10.1186/1472-6963-9-15.10.1186/1472-6963-9-15265444319171057
  2. 2. Ministry of Health - National Centre of Public Health and Analyses. Hospitalized Patients (discharged and deceased) in Hospitals of ICD-10 [displayed 22 July 2014]. Available at http://www.webcitation.org/6RGLCGLuy
  3. 3. Ministry of Health - National Statistical Institute. Здравеопазване 2013 [Healthcare 2013, in Bulgarian] [displayed 22 July 2014]. Available at http://www.webcitation.org/6RVn1cCWV
  4. 4. Marginean I, Precupetu I, Tzanov V, Preoteasa AM, Voicu B. First European Quality of Life Survey: Quality of life in Bulgaria and Romania. Luxembourg: Office for Official Publications of the European Communities; 2006 [displayed 22 July 2014]. Available at http://www.eurofound.europa.eu/pubdocs/2006/67/en/1/ef0667en.pdf
  5. 5. Dimova A, Rohova M, Moutafova E, Atanasova E, Koeva S, Panteli D, van Ginneken E. Bulgaria health system review. Health Syst Transit 2012;14:1-186. PMID: 22894828
  6. 6. Andreeva VA, Sakuma KL. Adapting smoking cessation programming to the Bulgarian context. Eval Health Prof 2008;31:290-6. doi: 10.1177/016327870832014910.1177/016327870832014918559883
  7. 7. Stefanov TS, Temelkova-Kurktschiev TS. The metabolic syndrome in Bulgaria. Folia Med (Plovdiv) 2011;53:5-14. doi: 10.2478/v10153-011-0061-210.2478/v10153-011-0061-222708468
  8. 8. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S; INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-40. doi: 10.1093/eurheartj/ehn01810.1093/eurheartj/ehn01818334475
  9. 9. Babisch W. Updated exposure-response relationship between road traffic noise and coronary heart diseases: A metaanalysis. Noise Health 2014;16:1-9. doi: 10.4103/1463-1741.127847.10.4103/1463-1741.12784724583674
  10. 10. Goines L, Hagler L. Noise pollution: a modem plague. South Med J 2007;100:287-94. PMID: 1739673310.1097/SMJ.0b013e3180318be517396733
  11. 11. Andersson K, Lindvall T. Health Effects of Community Noise; Evaluation of the Nordic Project on “The Health Effects of Community Noise”. Copenhagen: Nordic Council of Ministers; 1988.
  12. 12. Spreng M. Central nervous system activation by noise. Noise Health 2000;2:49-58. PMID: 12689471
  13. 13. Ising H, Kruppa B. Health effects caused by noise: evidence in the literature from the past 25 years. Noise Health 2004;6:5-13. PMID: 15070524
  14. 14. Westman JC, Walters JR. Noise and stress: a comprehensive approach. Environ Health Perspect 1981;41:291-309. PMID: 733324310.1289/ehp.814129115688507333243
  15. 15. WHO Regional Office for Europe. Burden of Disease from Environmental Noise. Quantification of Healthy Life Years Lost in Europe. Copenhagen: WHO Regional Office for Europe; 2011.
  16. 16. Noise Observation and Information Service for Europe (NOISE). Copenhagen, European Environment Agency [displayed 22 July 2014G. Available at http://noise.eionet.europa.eu/
  17. 17. Berglund B, Lindvall T, Schwella DH, editors. Guidelines for Community Noise. Geneva: World Health Organization; 1999 [displayed 22 July 2014]. Available at http://www.who.int/docstore/peh/noise/noiseindex.html
  18. 18. Ricardo-AEA. Update of the Handbook on External Costs of Transport - Report for the European Commission: DG MOVE; 2014 [displayed 22 July 2014]. Available at http://ec.europa.eu/transport/themes/sustainable/studies/doc/2014-handbook-external-costs-transport.pdf
  19. 19. Harding AH, Frost GA, Tan E, Tsuchiya A, Mason HM. The cost of hypertension-related ill-health attributable to environmental noise. Noise Health 2013;15:437-45. doi: 10.4103/1463-1741.12125310.4103/1463-1741.12125324231422
  20. 20. Paunovic K, Belojević G. Burden of myocardial infarction attributable to road-traffic noise: A pilot study in Belgrade. Noise Health 2014;16:374-9. doi: 10.4103/1463-1741.14441510.4103/1463-1741.14441525387533
  21. 21. Laaksonen M. Population Attributable Fraction (PAF) in Epidemiologic Follow-up Studies [PhD thesis]. Helsinki: National Institute for Health and Welfare, Finland; 2010 [displayed 22 July 2014]. Available at http://www.webcitation.org/6RGXvijCr
  22. 22. Kirkdale R, Krell J, O’Hanlon Brown C, Tuthill M, Waxman J. The cost of a QALY. QJM 2010;103:715-20. doi: 10.1093/ qjmed/hcq08110.1093/qjmed/hcq08120519275
  23. 23. Mathers CD, Bernard C, Iburg KM, Inoue M, Fat DM, Shibuya K, Stein C, Tomijima N, Xu H. Global Burden of Disease in 2002: Data sources, methods and results. World Health Organisation; 2003 (Revised February 2004) [displayed 22 July 2014]. Available at http://www.who.int/healthinfo/paper54.pdf
  24. 24. van Domburg RT, Sonnenschein K, Nieuwlaat R, Kamp O, Storm CJ, Bax JJ, Simoons ML. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 2005;46:15-20. doi: 10.1016/j. jacc.2005.03.047
  25. 25. Annemans L, Lamotte M, Clarys P, Van den Abeele E. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Eur J Cardiovasc Prev Rehabil 2007;14:815-24. doi: 10.1097/HJR.0b013e3282ef514f10.1097/HJR.0b013e3282ef514f18043305
  26. 26. Riegelman R. Non-communicable diseases. In: Public Health 101: Healthy People - Healthy Populations. London: Jones and Bartlett Publishers; 2010. p. 94.
  27. 27. European Commission, EUROSTAT. GDP and beyond, Measuring quality of life in the EU; 2014 [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-19032014-CP/EN/3-19032014-CP-EN.PDF
  28. 28. European Commission, EUROSTAT. Annual national accounts (nama) [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY_SDDS/EN/nama_esms.htm
  29. 29. Ministry of Health. [National Invasive Cardiology Registry, in Bulgarian]. [displayed 22 July 2014]. Available at http:// www.mh.government.bg/
  30. 30. den Boer LC, Schroten A. Traffic noise reduction in Europe. Report. CE Delft; 2007 [displayed 22 July 2014]. Available at http://www.transportenvironment.org/sites/te/files/media/2008-02_traffic_noise_ce_delft_report.pdf
  31. 31. Poirazis H. Double Skin Façades: A Literature Review. A report of IEA SHC Task 34 ECBCS Annex 43; 2006 [displayed 22 July 2014]. Available at http://www.ecbcs.org/docs/Annex_43_Task34-Double_Skin_Facades_A_Literature_Review.pdf
  32. 32. Dzhambov AM, Dimitrova DD. Urban green spaces’ effectiveness as a psychological buffer for the negative health impact of noise pollution: A systematic review. Noise Health 2014;16:157-65. doi: 10.4103/1463-1741.134916.10.4103/1463-1741.13491624953881
  33. 33. World Health Organization (WHO). Evaluation and Use of Epidemiological Evidence for Environmental Health Risk Assessment. Guideline document. Copenhagen: WHO Regional Office for Europe, 2000 [displayed 20 June 2014]. Available at http://www.euro.who.int/document/e68940.pdf
  34. 34. De Smedt D, Kotseva K, De Bacquer D, Wood D, De Backer G, Dallongeville J, Seppo L, Pajak A, Reiner Z, Vanuzzo D, Georgiev B, Gotcheva N, Annemans L. Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. Eur Heart J 2012;33:2865-72. doi: 10.1093/eurheartj/ehs21010.1093/eurheartj/ehs21022843446
  35. 35. Petrova G, Ivanova A, Czech M, Valov V, Wrona W, Niewada M, Savova A. Liraglutide vs. Exenatide in Combination with Metformin and/or Sulfonylurea Therapy in Type 2 Diabetes Mellitus Therapy in Bulgaria. A Modelling Study. Comptes rendus de l’Acade’mie bulgare des Sciences 2011;64:1507-14.
  36. 36. Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006;21:402-8. doi: 10.1093/heapol/czl018 10.1093/heapol/czl01816877455
DOI: https://doi.org/10.1515/aiht-2015-66-2562 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 15 - 21
Submitted on: Aug 1, 2014
Accepted on: Jan 1, 2015
Published on: Mar 27, 2015
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Angel M. Dzhambov, Donka D. Dimitrova, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.